Press "esc" to clear
Go to Advanced Search

Showing results

110 of 3324

Article ID: 701038

Limited Conclusions Can be Drawn from Study on Limiting Antithrombotic Therapy Beyond One Year for Stent Patients with Atrial Fibrillation

Cardiovascular Research Foundation (CRF)

The first randomized trial of its kind was unable to establish non-inferiority of oral anticoagulation (OAC) alone to combined OAC and a single antiplatelet agent (APT) in patients with atrial fibrillation (AF) and stable coronary artery disease beyond one year after stent implantation.

Released:
24-Sep-2018 5:00 PM EDT

Article ID: 701037

NIRS-IVUS Detects Patients and Plaques Vulnerable to Subsequent Adverse Coronary Events

Cardiovascular Research Foundation (CRF)

Results from the Lipid-Rich Plaque (LRP) study demonstrate the correlation between the presence of non-flow-limiting, non-intervened upon, lipid-rich plaques detected by NIRS-IVUS imaging and the development of a major adverse cardiac event (MACE) from a de novo culprit lesion at both the patient level (vulnerable patients) and segment level (vulnerable plaques) within 24 months post intravascular imaging.

Released:
24-Sep-2018 4:55 PM EDT

Article ID: 701036

Multicenter Study Finds IVUS-Guided Drug-Eluting Stent Implantation Improves Clinical Outcomes in All-Comer Patients

Cardiovascular Research Foundation (CRF)

The first study designed to determine the benefits of intravascular ultrasound (IVUS) guidance over angiography guidance during drug-eluting stent (DES) implantation in all-comer patients found that IVUS improved clinical outcomes by lowering the rate of target vessel failure at one year.

Released:
24-Sep-2018 4:55 PM EDT

Article ID: 701009

Aria CV Wins TCT 2018 Shark Tank Competition

Cardiovascular Research Foundation (CRF)

The Cardiovascular Research Foundation (CRF) is pleased to announce that Aria CV has won the TCT 2018 Shark Tank Competition which took place during the Transcatheter Cardiovascular Therapeutics (TCT) 2018, the world’s premier educational meeting specializing in interventional cardiovascular medicine. The winner was also presented with the Jon DeHaan Foundation Award for Interventional Innovation today in the Main Arena of the San Diego Convention Center.

Released:
24-Sep-2018 1:05 PM EDT
  • Embargo expired:
    23-Sep-2018 3:35 PM EDT

Article ID: 700950

Prosthetic Valve Mismatches Common in Transcatheter Valve Replacement Procedure, Increasing Risk of Death

Perelman School of Medicine at the University of Pennsylvania

In the largest multi-institutional study to date, led by researchers from Penn Medicine, the team found that among patients who underwent a transcatheter aortic valve replacement, a high number experienced severe and moderate cases of prosthesis-patient mismatch. The team also found that the risk of death and of heart failure readmissions were higher.

Released:
23-Sep-2018 4:15 PM EDT

Article ID: 700964

Transcatheter Device Used to Treat Secondary Mitral Valve Regurgitation in Heart Failure Patients Reduces Hospitalizations, Enhances Quality of Life, and Improves Survival

Cardiovascular Research Foundation (CRF)

Data presented today from the randomized COAPT trial, which have the potential to significantly change current clinical practice, found that patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic despite maximally tolerated medical therapy demonstrated reduced rates of hospitalizations and death, as well as improved quality-of-life and functional capacity after being treated with the transcatheter MitraClip device.

Released:
23-Sep-2018 3:05 PM EDT

Article ID: 700965

Study Finds Similar Outcomes with Two Different Valve Types as well as Similar Outcomes with Anesthesia Types during Transcatheter Aortic Valve Replacement

Cardiovascular Research Foundation (CRF)

The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (TAVR) in patients with intermediate to high surgical risk found local anesthesia to be both safe and effective. In addition, the study found that a current generation balloon-expandable valve had similar outcomes to a current generation self-expanding one.

Released:
23-Sep-2018 3:05 PM EDT
  • Embargo expired:
    23-Sep-2018 1:20 PM EDT

Article ID: 700754

Minimally Invasive Procedure Significantly Improved Outcomes for Heart Failure Patients with Mitral Regurgitation

New York-Presbyterian Hospital

A multicenter clinical trial has found that a minimally invasive procedure called transcatheter mitral valve repair significantly reduced hospitalizations and mortality for heart failure patients with moderate-to-severe or severe functional mitral regurgitation.

Released:
22-Sep-2018 1:20 PM EDT

Article ID: 700962

Novel Drug-Eluting Stent with Improved Radiographic Visibility Found to Be Safe and Effective

Cardiovascular Research Foundation (CRF)

This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.

Released:
22-Sep-2018 6:05 PM EDT

Article ID: 700963

Novel Polymer-Free Amphilimus-Eluting Stent is Noninferior to Durable Polymer Zotarolimus-Eluting Stent

Cardiovascular Research Foundation (CRF)

The first large, randomized trial comparing a novel polymer-free amphilimus-eluting stent to the latest-generation permanent polymer drug-eluting stent found that the polymer-free stent was clinically safe and effective.

Released:
22-Sep-2018 6:05 PM EDT

Showing results

110 of 3324

Chat now!